Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes
- 1 August 2003
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 61 (2) , 133-136
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes MellitusArchives of internal medicine (1960), 2000
- Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patientsKidney International, 2000
- Diabetic retinopathy in a black populationOphthalmology, 1999
- A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.Diabetes, 1999
- PAI-1 Plasma Levels in a General Population Without Clinical Evidence of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Diabetic Retinopathy, Promoter (4G/5G) Polymorphism of PAI-1 Gene, and PAI-1 Activity in Pima Indians With Type 2 DiabetesDiabetes Care, 1997
- Epidemiology and genetics of diabetic complicationsDiabetologia, 1997
- Defective homocysteine metabolism as a risk factor for diabetic retinopathyThe Lancet, 1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studiesNucleic Acids Research, 1991